U.S. Physical Therapy, Inc. (NYSE:USPH) Receives $110.25 Average PT from Brokerages

Shares of U.S. Physical Therapy, Inc. (NYSE:USPH) have been given an average recommendation of “Moderate Buy” by the eight brokerages that are currently covering the firm, Marketbeat Ratings reports. Three equities research analysts have rated the stock with a hold recommendation, four have issued a buy recommendation and one has assigned a strong buy recommendation to the company. The average 1-year price target among analysts that have covered the stock in the last year is $110.25.

A number of analysts have recently commented on USPH shares. Weiss Ratings reissued a “hold (c)” rating on shares of U.S. Physical Therapy in a research report on Wednesday, October 8th. JPMorgan Chase & Co. assumed coverage on U.S. Physical Therapy in a report on Thursday, September 18th. They issued an “overweight” rating and a $110.00 target price on the stock. Wall Street Zen downgraded U.S. Physical Therapy from a “buy” rating to a “hold” rating in a report on Sunday, September 21st. Barrington Research upped their price target on shares of U.S. Physical Therapy from $98.00 to $103.00 and gave the stock an “outperform” rating in a research note on Friday, August 8th. Finally, Zacks Research upgraded shares of U.S. Physical Therapy to a “hold” rating in a research note on Friday, August 8th.

Insider Buying and Selling

In related news, CEO Christopher J. Reading sold 2,000 shares of the company’s stock in a transaction that occurred on Thursday, September 4th. The stock was sold at an average price of $83.53, for a total value of $167,060.00. Following the transaction, the chief executive officer directly owned 114,088 shares of the company’s stock, valued at approximately $9,529,770.64. This represents a 1.72% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Also, Director Nancy Ham sold 600 shares of the stock in a transaction on Thursday, September 11th. The shares were sold at an average price of $81.71, for a total value of $49,026.00. Following the sale, the director owned 1,994 shares in the company, valued at approximately $162,929.74. This represents a 23.13% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 6,853 shares of company stock worth $581,406 over the last 90 days. 2.00% of the stock is currently owned by company insiders.

Hedge Funds Weigh In On U.S. Physical Therapy

Several hedge funds and other institutional investors have recently bought and sold shares of the stock. Copeland Capital Management LLC raised its holdings in shares of U.S. Physical Therapy by 8.9% during the second quarter. Copeland Capital Management LLC now owns 888,735 shares of the company’s stock valued at $69,499,000 after purchasing an additional 72,463 shares during the last quarter. Geode Capital Management LLC grew its position in U.S. Physical Therapy by 1.2% in the 2nd quarter. Geode Capital Management LLC now owns 352,923 shares of the company’s stock worth $27,602,000 after purchasing an additional 4,306 shares during the period. Envestnet Asset Management Inc. grew its position in U.S. Physical Therapy by 9.4% in the 2nd quarter. Envestnet Asset Management Inc. now owns 346,160 shares of the company’s stock worth $27,070,000 after purchasing an additional 29,671 shares during the period. Bahl & Gaynor Inc. grew its position in U.S. Physical Therapy by 32.6% in the 1st quarter. Bahl & Gaynor Inc. now owns 345,003 shares of the company’s stock worth $24,964,000 after purchasing an additional 84,878 shares during the period. Finally, GW&K Investment Management LLC grew its position in U.S. Physical Therapy by 8.9% in the 1st quarter. GW&K Investment Management LLC now owns 344,390 shares of the company’s stock worth $24,920,000 after purchasing an additional 28,203 shares during the period.

U.S. Physical Therapy Price Performance

Shares of USPH stock opened at $89.25 on Tuesday. The stock has a market cap of $1.36 billion, a price-to-earnings ratio of 38.97, a PEG ratio of 4.59 and a beta of 1.48. The business’s fifty day moving average is $84.85 and its 200 day moving average is $77.83. U.S. Physical Therapy has a twelve month low of $62.77 and a twelve month high of $101.19. The company has a quick ratio of 1.18, a current ratio of 1.18 and a debt-to-equity ratio of 0.30.

U.S. Physical Therapy (NYSE:USPH) last posted its quarterly earnings data on Tuesday, August 22nd. The company reported $0.90 EPS for the quarter. The business had revenue of $140.66 million for the quarter. U.S. Physical Therapy had a net margin of 5.05% and a return on equity of 8.78%. Research analysts expect that U.S. Physical Therapy will post 2.67 EPS for the current fiscal year.

U.S. Physical Therapy Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Friday, September 12th. Investors of record on Friday, August 22nd were given a dividend of $0.45 per share. The ex-dividend date of this dividend was Friday, August 22nd. This represents a $1.80 annualized dividend and a dividend yield of 2.0%. U.S. Physical Therapy’s dividend payout ratio (DPR) is 78.60%.

About U.S. Physical Therapy

U.S. Physical Therapy, Inc operates outpatient physical therapy clinics. The company operates through Physical Therapy Operations and Industrial Injury Prevention Services segments. The company provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.